Pancreatic Cancer Research

ResearcherHunan UniversityActive in the last 2 years

Mao Ye

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4798-1825; OpenAlex author ID A5028541942. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Corrigendum to Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci211838↗
  2. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1172/jci187024↗
  3. IFNα-induced BST2+ tumor-associated macrophages facilitate immunosuppression and tumor growth in pancreatic cancer by ERK-CXCL7 signaling. Co-author DOI 10.1016/j.celrep.2024.114088↗
  4. Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis. Co-author DOI 10.1016/j.hpb.2020.01.001↗
  5. Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages. Co-author DOI 10.1038/s41416-019-0595-2↗
  6. DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition. Co-author DOI 10.7150/thno.11938↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingbo Liang · 3 shared papers, 2019–2025 · strength 0.43
  2. Xiao Zhi · 2 shared papers, 2025–2026 · strength 0.37
  3. Xiongbin Lu · 2 shared papers, 2025–2026 · strength 0.37
  4. Kang Sun · 2 shared papers, 2025–2026 · strength 0.37
  5. Jinyuan Song · 2 shared papers, 2025–2026 · strength 0.37
  6. Mengyi Lao · 2 shared papers, 2025–2026 · strength 0.37
  7. Xueli Bai · 2 shared papers, 2019–2025 · strength 0.25
  8. Qihan Fu · 2 shared papers, 2019–2020 · strength 0.21
  9. Tingbo Liang · 1 shared paper, 2026 · strength 0.20
  10. Xiaobao Wei · 1 shared paper, 2024 · strength 0.18
  11. Jiangchao Wu · 1 shared paper, 2024 · strength 0.18
  12. Junli Wang · 1 shared paper, 2024 · strength 0.18
  13. Yi Duan · 1 shared paper, 2024 · strength 0.18
  14. Yunhua Liu · 1 shared paper, 2024 · strength 0.18
  15. Chenlei Zheng · 1 shared paper, 2024 · strength 0.18
  16. Bo Kong · 1 shared paper, 2024 · strength 0.18
  17. Hanshen Yang · 1 shared paper, 2025 · strength 0.17
  18. Xiang Li Ma · 1 shared paper, 2025 · strength 0.17
  19. Lihong He · 1 shared paper, 2025 · strength 0.17
  20. Lingyue Liu · 1 shared paper, 2025 · strength 0.17
  21. Xiang Li · 1 shared paper, 2020 · strength 0.13
  22. Qi Zhang · 1 shared paper, 2020 · strength 0.13
  23. Yiwen Chen · 1 shared paper, 2020 · strength 0.13
  24. Tingbo Liang · 1 shared paper, 2020 · strength 0.13
  25. Xueli Bai · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.